Skip to content
TrialScanner

NCT02543229

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Phase 1CompletedCKDXFLead

Registry record

Lead sponsor
Opthea Limited
Conditions
Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Degeneration; Neovascularization, Pathologic
Primary completion
Feb 7, 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02543229 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02543229: Study Evaluating the Safety... | TrialScanner